English | 中文

microconstants > microconstants > news > Company News > Liver Cancer Drug Candidate PTX-9908 Received Taiwan FDA IND Approval

Liver Cancer Drug Candidate PTX-9908 Received Taiwan FDA IND Approval

2019-07-12 10:37:09

http://www.gbimonthly.com/2019/06/48587/

previous：MicroConstants China completed a TQT study for a new drug registration in China
next：MicroConstants China Liver Cancer Drug PTX-9908 Received IND Approval from China